Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapalogues for Autism in TSC
NCT01929642Phase 2Completed
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger
- Start
- Jul 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus, everolimus in tuberous sclerosis complex (TSC), Autism Spectrum Disorder (ASD), sponsored by Hugo W. Moser Research Institute at Kennedy Krieger. Started Jul 2013; status: completed.
02
Drugs
sirolimuseverolimus
03
Conditions
tuberous sclerosis complex (TSC)Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01929642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01929642.